News

News

PR Newswire
May 15, 2024

Cortex Announces Appointment of Dr. Matthew Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, to its Board of Directors

Read More
Cision PR Newswire
February 1, 2024

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping for use in Atrial Fibrillation Ablation

Read More
Healio
February 9, 2023

Electrographic flow-guided ablation appears to benefit redo patients with nonparoxysmal AF

Read More
Cision PR Newswire
February 3, 2023

The FLOW-AF multicenter, randomized controlled trial shows Ablacon’s Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation

Read More
Cision PR Newswire
January 7, 2021

$30 Million Series B Financing and Expansion of Scientific Advisory Board

Read More
Cision PR Newswire
September 10, 2019

Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark

Read More
Cision PR Newswire
July 23, 2019

Ablacon Announces Closing of a $10 Million Venture Debt Facility and $2 Million Equity Investment from Western Technology Investment; Josef Koblish and Melissa Kong to Join the Company

Read More
Forbes
May 27, 2019

Forbes lists Ablacon “25 Top Machine Learning Startups To Watch In 2019”

Read More
Cision PR Newswire
April 30, 2019

Ablacon, Inc. Raises $21.5M Series A to Advance AI-Enabled Atrial Fibrillation Mapping System

Read More